Big Gain For Orphazyme A/S
Thu, Mar 17, 2022 at 05:30 PM
Orphazyme A/S (ORPH:NASDAQ) shot up at $0.9, a gain of 37.4%. On Tue, Mar 15, 2022, ORPH:NASDAQ touched a New 2-Week Low of $0.57. The stock got featured on our News Catalysts scanner on Thu, Mar 10, 2022 at 04:29 PM in the 'MISCELLANEOUS' category. From Tue, Mar 01, 2022, the stock recorded 30.00% Up Days and 45.45% Green Days
The stock spiked on Thu, Mar 10, 2022 at $1.37 with a volume of 1M+.
About Orphazyme A/S (ORPH:NASDAQ)
Orphazyme AS is a late-stage biopharmaceutical company harnessing the amplification of Heat Shock Proteins.
Top 10 Gainers:
- Kidpik Corp. (PIK:NASDAQ), 158.15%
- Marrone Bio Innovations, Inc. (MBII:NASDAQ), 49.7%
- TC BioPharm (Holdings) plc (TCBP:NASDAQ), 45%
- Eiger BioPharmaceuticals, Inc. (EIGR:NASDAQ), 40.25%
- Mullen Automotive Inc. (MULN:NASDAQ), 39.43%
- Synthetic Biologics, Inc. (SYN:NYSEMKT), 37.56%
- Orphazyme A/S (ORPH:NASDAQ), 37.4%
- Innodata Inc. (INOD:NASDAQ), 34.33%
- Neonode Inc. (NEON:NASDAQ), 33.02%
- Cingulate Inc. (CING:NASDAQ), 31.62%